Scholarlink

<p>Fibromyalgia is a widespread painful condition prevalent in women. The main manifestations include spontaneous pain, mechanical and thermal allodynia, and comorbid symptoms such as fatigue and migraine, impacting the patients’ quality of life. Treatments for this disease have limited effectiveness and cause adverse effects, making it necessary to search for alternative therapies. Stigmasterol is a phytosterol with antinociceptive effects in clinically relevant experimental pain models. Therefore, we investigated stigmasterol’s effect on painful and fatigue-like symptoms in a reserpine-induced experimental fibromyalgia model in mice. Adult female C57BL/6 mice received reserpine subcutaneously (1&#xa0;mg/kg) once a day for three consecutive days. Mice submitted to the fibromyalgia model developed plantar mechanical and cold allodynia, mechanical-induced affective-motivational behaviour, heat thermal hyperalgesia, loss of muscle strength, and periorbital mechanical allodynia. Stigmasterol (0.3, 1, and 3&#xa0;mg/kg, single dose, orally) reduced plantar mechanical allodynia and mechanical-induced affective-motivational behaviour in a time- and dose-dependent manner. Stigmasterol (3&#xa0;mg/kg, orally) also reduced cold allodynia, heat thermal hyperalgesia, periorbital mechanical allodynia, and loss of muscle strength caused by reserpine, without causing motor impairment. Pregabalin (30&#xa0;mg/kg, orally), Food and Drug Administration-approved for fibromyalgia treatment, and sumatriptan (0.6&#xa0;mg/kg, orally), an anti-migraine drug, were used as reference drugs and reduced the nociceptive behaviours caused by reserpine. Our findings demonstrate that stigmasterol attenuated nociplastic pain and fatigue-like symptoms in the reserpine-induced fibromyalgia model in mice, highlighting its potential as a promising therapeutic candidate for alleviating pain-related symptoms in fibromyalgia.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Stigmasterol attenuates nociplastic pain and fatigue-like symptoms in a reserpine-induced fibromyalgia model in mice

  • 期刊论文

  • 发表日期：

    2025年12月8日

查看全文
  • Ana Clara Perazzio,
  • João Pedro V. Lopes,
  • Gabriela Becker,
  • Evelyne Silva Brum,
  • Sara Marchesan Oliveira

摘要

Fibromyalgia is a widespread painful condition prevalent in women. The main manifestations include spontaneous pain, mechanical and thermal allodynia, and comorbid symptoms such as fatigue and migraine, impacting the patients’ quality of life. Treatments for this disease have limited effectiveness and cause adverse effects, making it necessary to search for alternative therapies. Stigmasterol is a phytosterol with antinociceptive effects in clinically relevant experimental pain models. Therefore, we investigated stigmasterol’s effect on painful and fatigue-like symptoms in a reserpine-induced experimental fibromyalgia model in mice. Adult female C57BL/6 mice received reserpine subcutaneously (1 mg/kg) once a day for three consecutive days. Mice submitted to the fibromyalgia model developed plantar mechanical and cold allodynia, mechanical-induced affective-motivational behaviour, heat thermal hyperalgesia, loss of muscle strength, and periorbital mechanical allodynia. Stigmasterol (0.3, 1, and 3 mg/kg, single dose, orally) reduced plantar mechanical allodynia and mechanical-induced affective-motivational behaviour in a time- and dose-dependent manner. Stigmasterol (3 mg/kg, orally) also reduced cold allodynia, heat thermal hyperalgesia, periorbital mechanical allodynia, and loss of muscle strength caused by reserpine, without causing motor impairment. Pregabalin (30 mg/kg, orally), Food and Drug Administration-approved for fibromyalgia treatment, and sumatriptan (0.6 mg/kg, orally), an anti-migraine drug, were used as reference drugs and reduced the nociceptive behaviours caused by reserpine. Our findings demonstrate that stigmasterol attenuated nociplastic pain and fatigue-like symptoms in the reserpine-induced fibromyalgia model in mice, highlighting its potential as a promising therapeutic candidate for alleviating pain-related symptoms in fibromyalgia.